TOP > English > corporate profile

 Corporate Profile



 Aiming to be your trusted partner

 Try Angle Inc. has been acquired results as the team of professionals which is well versed in nonclinical  and clinical trial for development of pharmaceutical products. In our current climate, in which there is an acceleration in the pharmaceutical product development process and outsourcing of services, there is a demand for experts that are not only versed in the preparation of documents, translation, and quality check(QC), but those who are also specialists in pharmaceutical product development and are proficient in the entire process from drafting application forms to corresponding with relevant authorities. 


We will contribute towards product developments by standing on the same footing as clients and facing them at the working-level not only as your best commentator but also as your trustful cooperator.

Try Angle will fulfill the client needs as a team of professionals specialized in developing pharmaceutical products.

Our support service is formed from following principals.



 1. Draft the various application materials for pharmaceutical products.

 2. Translate both application forms and test reports on the pharmaceutical products.

 3. QC (consistency check) for application documents of pharmaceutical products.

 4. Provide the consulting on the development of pharmaceutical products.

 5. Support business on the reliability assurance of pharmaceutical etc.

 6. Translational support business in pharmaceutical  development.

 7. Electronic application of application materials involved in the manufacture and

     sale permit application of pharmaceutical products (CDISC-SEND) support business.

 8. Agency business for nonclinical research organization (so called CRO).


 We prepare the support system with various services, such as designing test plan, the analysis and collation of data, evaluation of the related papers, and drafting the application forms for pharmaceutical products, medical equipment, unregulated drugs, cosmetics, food products,  agricultural chemicals, and general chemical substances. 

Please utilize Try Angle Inc. Ltd. in order to promote more exact and efficient development of your products in a short period of time.

   Try Angle Inc.          

 Ryuji Koga, CEO  


We can sugget just your "SOLUTION". 

Corporate Profile 

Company name

Try Angle Inc.


Head Office / Tokyo office

Shinwa Bldg 5F, 3-2-4, Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023

<Document Solutions>

Tel: +81 (3) 5909-7028    Fax: +81 (3) 5909-7029

 <Representative / Staffing Dept.>

Tel: +81 (3) 5325-5600    Fax: +81 (3) 5325-5611


Osaka office

Daiei Bldg 4F, 1-12-7, Shibata, Kita-ku, Osaka-shi, Osaka, 530-0012

Tel: +81 (6) 6292-0070    Fax: +81 (6) 6292-0071


Tsukuba office

Green Palace Koyadai 101, 2-12-2, Koyadai, Tsukuba-shi, Ibaraki, 305-0074

Tel: +81 (29) 838-2760    Fax: +81 (29) 838-2760


CEO  Ryuji Koga


July 1, 2009

Stated capital

55 million Yen
Duties contents

-Draft, translate and QC (consistency check) the materials of Product manufacturing license application as well as the related materials on pharmaceutical products, an unregulated drug, medical equipment, agricultural chemicals, a drug for animal, cosmetics, and functional foods.

-Development support service for pharmaceutical products, an unregulated drug, medical equipments, agricultural chemicals, a drug foranimal, cosmetics, and functional foods.

-Development, Clinical support & Staffing Service



Mizuho bank, Ikebukuro branch

Sumitomo Mitsui Banking Corporation, Ikebukuro branch

MUFG Bank, Ikebukuro-higashiguchi branch


Foreign-affiliated pharmaceutical company    27 companies

Domestic pharmaceutical company               55 companies

Companies other than medical supplies         53 companies

Access map

Head office

Via JR(Japan Railway), all subway lines, and private lines-10 minutes on foot from "Shinjuku" station 

Head office

History of Three S Japan

April, 2002

The development support division was established in Histo Science Laboratory Co., Ltd. and started document preparation for the application.
July, 2003 The development support division changed its name to Three S Japan, and the Tokyo office was established.
November, 2006  Three S Japan was separated from Histo Science Laboratory Co., Ltd. and Three S Japan Co., Ltd. was established as an independent company.
September,2007 The Osaka office was established.
February,2011 The Kobe office was established.
April,2011 Gained the license for Specified Worker Dispatching Undertakings(特 13-313825)
November, 2011 The Osaka office was relocated to Hiranomachi.
October, 2012

The head office was relocated in the Minami-Ikebukuro area to expand the business.

March, 2013

Business Alliance and Contracted with WIL RESEARCH COMPANY, INC. for the exclusive agency in Japan.

March, 2014

Business Alliance with PDS Lifescience Ltd.   Started SEND Solution Services.

October, 2015 Buness Alliance and Contracted with ViruSure GmbH for the exclusive agency in Japan.
June, 2016 Business Alliance and Contracted with Southern Research for the exclusive agency in Japan.
October, 2016 Released the exclusive agreement with WIL RESEARCH COMPANY, INC.
October, 2016 Business Alliance and Contracted with IES Ltd., for the exclusive agency in Japan.
November, 2016 Business and Capital Alliance with OUTSOURCING INC.  Three S Japan is one of OUTSOURCING Group companies.
November, 2016 10th Anniversary of Foundation for Three S Japan.
December, 2016 Business Alliance with Accelera for the agency in Japan.
July, 2017 Head Office moved to Shinjuku.
January, 2019 Manegement Integration with Try Angle Inc.

Main staffs


CEO  Ryuji Koga


(Scientific Advisor)

Koichi Hagita (Toxicology)

Toshiyuki Fujii, Medical doctor (Toxicology, Pathology)

Shigetaka Koda, Doctor of pharmacology (CMC)

Takashi Igarashi, Doctor of pharmacology (Pharmacokinetics)

Kanemasa Katsu, Medical doctor (Reliability Assurance)

Kunio Nakayama, Specialist (Reliability Assurance)

Mamoru Nomura (Toxicology)

Takayoshi Kobayashi (Toxicology)

Keizo Yoshida (Toxicology, Clinical Development)

Shiro Higuchi (Reliability Assuarance)

Kazuhiko Matsumoto (Statistics)

Document Solutions Department

Medical Writing Group 34
QC Group 52
Translation Group 29